U.S. Diversified Financial Stock News

Avanos Medical (AVNS) continues to trade around $24.98, drawing attention from investors who are weighing its medical device portfolio against mixed financial metrics, including modest annual revenue growth and a reported net loss. See our latest analysis for Avanos Medical. Over the past year Avanos Medical’s share price return has moved sharply higher, with a year to date share price return of 123.43% and a 1 year total shareholder return of 106.28%. However, the 5 year total shareholder...

Alexander's (ALX) continues to draw attention after recent share price moves alongside its latest reported figures, including US$211.68 million in revenue and US$20.57 million in net income from its New York focused real estate portfolio. See our latest analysis for Alexander's. At a latest share price of US$276.53, Alexander's has seen a 26.35% year to date share price return and a 16.80% total shareholder return over the past year, with the recent 1 day decline of 3.35% tempering what has...

Small caps sit at the crossroads of several powerful forces right now, from a US equity market trading at an 8% discount to fair value to shifting views on inflation, interest rates, and credit risk. For investors willing to look beyond the largest technology and AI stocks, this mix of lower valuations and changing macro conditions can create both opportunities and traps. This article breaks down what the recent news on inflation, Federal Reserve policy, and credit markets could mean for...

Cardinal Health (NYSE:CAH) has agreed to acquire Strive Medical, a provider of urology and wound care supplies for patients at home. The company is also buying AdaptHealth’s diabetes business, adding to its at-Home Solutions division. Both deals focus on expanding Cardinal Health’s home care offering in diabetes management and urology. The transactions are expected to be accretive to non-GAAP earnings within a year of closing. Cardinal Health enters these transactions with its stock at...

Univest Financial has delivered strong share price gains over the past three years, yet there is a clear split between valuation frameworks. The Excess Returns intrinsic value estimate points to upside, while earnings-based multiples look relatively rich. Univest Financial has returned 133.1% over the past three years, which puts extra focus on whether the current price already reflects much of the good news. The valuation debate hinges on how durable the bank's profitability and credit...

Travel + Leisure (TNL) has just posted Q2 2026 results with revenue of US$1,063 million and basic EPS of US$1.75, alongside trailing twelve month revenue of US$4.1 billion and EPS of US$3.73 that give investors a broader read on the current earnings run rate. Over the last six reported quarters, revenue has ranged from US$934 million to US$1,063 million while quarterly basic EPS has moved between a loss of US$0.95 and a profit of US$1.75. This sets the stage for investors to weigh the latest...

IonQ stock has delivered a very strong 249.2% return over the past 5 years, yet its current valuation checks lean expensive and recent share price weakness raises questions about how much optimism is already in the price. IonQ has returned 249.2% over 5 years, which puts long term holders in a strong position but also raises the bar for what future fundamentals may need to support. Fresh research around using IonQ’s trapped ion systems to cut energy use in AI workloads can support long term...

Cal-Maine Foods (CALM) closed out FY 2026 with fourth quarter revenue of US$552.6 million and a quarterly loss of US$35.9 million, or EPS of US$0.76, against a backdrop of trailing 12 month EPS of US$6.65 on revenue of US$2.9 billion. Over recent quarters, the company has seen revenue move from US$1.4 billion in Q3 FY 2025 and EPS of US$10.42 to US$922.6 million and EPS of US$4.13 in Q1 FY 2026, before landing at the latest reported levels. With trailing net profit margin now sitting at 10.9%...

Pegasystems (PEGA) has reported Q2 2026 revenue of US$420.7 million with basic EPS of US$0.08, alongside trailing 12 month revenue of about US$1.74 billion and basic EPS of US$1.92 that sit against a 47.2% earnings growth rate over the past year. Over recent quarters the company has seen revenue range between US$381.4 million and US$504.3 million, while quarterly EPS has moved between US$0.18 and US$1.38. This sets up the latest print against a period of rising trailing net margins from 13.1%...

SPS Commerce stock has fallen a long way over the last few years, yet current valuation checks suggest the shares are no longer clearly mispriced and instead screen as roughly in line with fundamentals. Over the past 3 years, SPS Commerce has declined 65.6%, which puts recent trading squarely in the context of a prolonged drawdown. For a subscription based software business like SPS Commerce, the main support for valuation can come from durable recurring revenue and margins. A key risk is...

East West Bancorp (EWBC) opened Q2 2026 with total revenue of US$735.3 million and basic EPS of US$2.65, supported by net income of US$363.7 million. The company reported revenue of US$632.0 million and EPS of US$2.25 in Q2 2025, compared with US$735.3 million and EPS of US$2.65 in Q2 2026. Trailing 12 month EPS stands at US$10.46 on revenue of US$2.89 billion. These figures provide a basis for investors to examine how the company’s net interest margin and cost efficiency affect the...

Metropolitan Bank Holding (MCB) has just posted Q2 2026 results with revenue of US$79.7 million and basic EPS of US$1.55, alongside trailing twelve month revenue of US$312.0 million and EPS of US$7.98. Over recent quarters, revenue has moved from US$69.9 million in Q2 2025 to US$85.6 million in Q4 2025 and US$90.8 million in Q1 2026 before this latest print. Quarterly EPS has ranged from US$0.68 in Q3 2025 to US$2.94 in Q1 2026, which puts the focus on how efficiently those earnings are being...

Xcel Energy stock has delivered a 36.9% total return over the past 5 years, yet the valuation checks now suggest the shares may be leaning expensive. The Dividend Discount Model (DDM) intrinsic value estimate points to a premium over the current fundamentals, while the broader multiples reading appears closer to fair. A 36.9% return over 5 years puts Xcel Energy in the camp of steady compounders. This often leaves less room for investors seeking a clear discount to intrinsic...

The race to treat obesity and diabetes is shifting again after Eli Lilly pushed back approval plans for its next-generation obesity drug, retatrutide, to Q1 2027, even as phase 3 data showed weight loss of up to 22.6% and blood sugar benefits. This mix of regulatory delay and clinical progress can reshape expectations for companies exposed to these therapies. For investors, it creates a fresh reason to reassess risk, timing and potential rewards. The sections that follow break down how three...

Earlier in July 2026, LightPath Technologies announced an US$11 million follow-on purchase order from a global technology customer for infrared cameras used in counter‑UAS applications, reinforcing demand from public safety and defense markets. A series of historical shelf registration closures and withdrawals through July 22, 2026 also highlights how LightPath has periodically tapped and adjusted its access to equity capital over time, including offerings tied to employee stock ownership...

Valmont Industries has delivered a 118.6% total return over the past 5 years, yet its current valuation checks suggest the stock still trades at a discount to an estimate of intrinsic value based on a Discounted Cash Flow (DCF) approach and market multiples. Over 5 years, Valmont Industries has returned 118.6%. This puts the recent pullback into context as a long run of gains rather than a short-term story. Investor optimism around long-term utility and infrastructure demand can support...

AAR (AIR) has just posted FY 2026 results capped by fourth quarter revenue of US$928 million and basic EPS of US$1.29, against a backdrop of very large year over year reported earnings growth and a net profit margin that now sits at 5.7%. Over the past year the company has seen trailing twelve month revenue reach US$3.3 billion and EPS climb to US$4.90. Reported earnings growth of 1,401.6% reflects a sharp shift from the prior year’s base. For investors, this combination of higher earnings...

CME Group (CME) has just posted its Q2 2026 numbers with revenue of US$1,706.2 million and basic EPS of US$2.89, set against a trailing twelve month backdrop of US$6.76 billion in revenue and EPS of US$11.77. The company has seen quarterly revenue move between US$1,534.4 million and US$1,876.2 million over the last six reported periods, while basic EPS has ranged from US$2.49 to US$3.25, giving investors a clear read on earnings power heading into this latest update. With trailing net margins...

Surging June inflation at 5%, rising rate hike expectations for 2026, and oil prices near six week highs due to the US Iran war have put Energy Sector Stocks, Oil & Gas Producers, firmly in the spotlight. Higher transport costs and fears of further supply disruption are reshaping how investors think about risk, pricing power, and cash flow resilience across this part of the market. This article picks out 3 stocks from the Energy Sector Stocks, Oil & Gas Producers screener that appear...

Union Pacific (NYSE:UNP) and Canadian National have signed a binding Memorandum of Understanding to expand cross border rail operating rights. The agreement is designed to improve freight flows between Canada, the US, and Mexico through key hubs such as Chicago and southern border gateways. The move focuses on more efficient rail connections for shippers using North American trade corridors. Union Pacific is a major freight railroad in the US, moving commodities, industrial goods, and...

Repligen (RGEN) has agreed to acquire BioLife Solutions in a roughly $1.5 billion deal, a move that immediately shifts investor focus to how a larger cell therapy footprint could influence the stock’s risk and reward profile. See our latest analysis for Repligen. Repligen’s share price has been volatile, with a 22.82% 90 day share price return and a 10.68% 30 day share price return contrasting with a decline of 14.76% year to date, while the 1 year total shareholder return of 19.60% hints at...

The quarterly results for Mercantile Bank Corporation ( NASDAQ:MBWM ) were released last week, making it a good time to...

American Tower stock has fallen 31.9% over the past five years, yet both its intrinsic value estimate based on a Discounted Cash Flow (DCF) approach and its earnings multiples currently point to an undervalued setup compared with the market price. Over the last five years, American Tower has declined 31.9%, which puts recent pricing against a weak return backdrop for long term holders. Goldman Sachs initiating coverage with a Buy rating and a US$215 target highlights confidence in American...

MSCI (MSCI) has laid out a clean set of numbers for Q2 2026, with revenue at US$867 million and basic EPS of US$4.70, set against a trailing twelve month EPS of US$18.29 and total revenue of about US$3.3 billion that highlight the scale of the business. Over the last year, the company has seen revenue move from US$2.9 billion to about US$3.3 billion and EPS rise from US$14.58 to US$18.29, giving investors a clear view of the revenue and earnings trajectory feeding into this quarter's print...